These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25729528)
1. Comorbidity is independently associated with poor outcome in extremity soft tissue sarcoma. Kang S; Kim HS; Kim W; Kim JH; Kang SH; Han I Clin Orthop Surg; 2015 Mar; 7(1):120-30. PubMed ID: 25729528 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in soft tissue sarcoma. Maretty-Nielsen K Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma. Kang S; Han I; Lee S; Kim W; Kim H Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153 [TBL] [Abstract][Full Text] [Related]
6. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Gustafson P Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499 [TBL] [Abstract][Full Text] [Related]
7. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Liu CY; Yen CC; Chen WM; Chen TH; Chen PC; Wu HT; Shiau CY; Wu YC; Liu CL; Tzeng CH Ann Surg Oncol; 2010 Aug; 17(8):2102-11. PubMed ID: 20217247 [TBL] [Abstract][Full Text] [Related]
8. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Lahat G; Dhuka AR; Lahat S; Lazar AJ; Lewis VO; Lin PP; Feig B; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Lev D Ann Surg Oncol; 2009 Sep; 16(9):2579-86. PubMed ID: 19557478 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic impact of comorbidity in soft tissue sarcoma: a population-based cohort study. Maretty-Nielsen K; Aggerholm-Pedersen N; Safwat A; Baerentzen S; Pedersen AB; Keller J Acta Oncol; 2014 Sep; 53(9):1188-96. PubMed ID: 24588412 [TBL] [Abstract][Full Text] [Related]
10. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities. Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas. Eilber FC; Brennan MF; Riedel E; Alektiar KM; Antonescu CR; Singer S Ann Surg Oncol; 2005 Mar; 12(3):228-36. PubMed ID: 15827815 [TBL] [Abstract][Full Text] [Related]
12. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project. Trovik CS; Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931. Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215 [TBL] [Abstract][Full Text] [Related]